The Global Bioequivalence Harmonization Initiative: Summary report for EUFEPS international conference-Reference-Cited by-同舟云学术

The Global Bioequivalence Harmonization Initiative: Summary report for EUFEPS international conference

Published:2018-01 Issue: Volume:111 Page:153-157
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Chen Mei-Ling,Blume Henning,Beuerle Gerald,Davit Barbara,Mehta Mehul,Potthast Henrike,Schug Barbara,Tsang Yu Chung,Wedemeyer Ralph-Steven,Weitschies Werner,Welink Jan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference24 articles.

1. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability;Amidon;Pharm. Res.,1995

2. The biopharmaceutics classification system (BCS): Class III drugs - better candidates for BA/BE waiver?;Blume;Eur. J. Pharm. Sci.,1999

3. Elucidating the role of dose in the biopharmaceutics classification of drugs: the concepts of critical dose, effective in vivo solubility, and dose-dependent BCS;Charkoftaki;Pharm. Res.,2012

4. Scientific considerations concerning the EMA change in the definition of “dose” of the BCS-based biowaiver guideline and implications for bioequivalence;Daousani;Int. J. Pharm.,2015

5. Towards determining appropriate hydrodynamic conditions for in vitro-in vivo correlations using computational fluid dynamics;D'Arcy;Eur. J. Pharm. Sci.,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Open forum conference on the ICH M13A bioequivalence guideline;European Journal of Pharmaceutical Sciences;2024-05

2. Global harmonization of immediate‐release solid oral drug product bioequivalence recommendations and the impact on generic drug development;Clinical and Translational Science;2023-11-14

3. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the fifth international EUFEPS/AAPS conference;European Journal of Pharmaceutical Sciences;2023-11

4. Exploring the Potential Challenges for Developing Generic Orphan Drugs for Rare Diseases: A Survey of US and European Markets;Value in Health Regional Issues;2023-05

5. Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms;The AAPS Journal;2022-03-11